DNA Chip Accurately Predicts Lung Cancer Metastasis

Strategic Insights -

Researchers from Chiba University in Japan, in collaboration with Hitachi Software Engineering Co. and DNA Chip Research Inc., have developed a DNA chip that can effectively predict whether lung cancer has spread to the lymph nodes. This breakthrough enables a more accurate diagnosis of cancer prognosis. The team analyzed 10,000 genes from tissue samples of lung cancer patients and identified a set of 1,300 genes associated with the disease. Based on this, a DNA chip was designed with probes for all these genes. Through testing with tissue samples from patients with and without lymph node metastasis, the team discovered 15 genes that serve as markers for metastasis. The DNA chip achieved an impressive accuracy of 84.6% in identifying such metastasis using these markers.

Key Takeaways:

  • The DNA chip, developed by Chiba University, Hitachi Software Engineering Co., and DNA Chip Research Inc., can accurately determine whether lung cancer has spread to the lymph nodes.
  • The chip achieved an accuracy of 84.6% in identifying metastasis through the analysis of 15 specific genes.
  • The team analyzed 10,000 genes from tissue samples of lung cancer patients, identifying 1,300 genes related to the disease.
  • Researchers tested the DNA chip with tissue samples from patients with and without lymph node metastasis.
  • The DNA chip's accuracy in predicting metastasis is higher than 80%, demonstrating its potential as a diagnostic tool.
  • Further testing is needed to verify the chip's effectiveness with new biopsy samples.
  • This breakthrough may lead to more accurate cancer prognosis and treatment planning.

Statistics:

  • The DNA chip achieved an accuracy of 84.6% in identifying lung cancer metastasis.
  • The chip was tested with tissue samples from 10,000 genes, identifying 1,300 genes associated with lung cancer.
  • The analysis revealed 15 specific genes (markers) that indicate lymph node metastasis.
  • The accuracy of 84.6% is higher than the 80% demonstrated in initial tests.
  • The collaboration between Chiba University, Hitachi Software Engineering Co., and DNA Chip Research Inc. aims to improve the diagnostic tool.

Sources:

  • Nikkei
  • Asia Pulse